Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Journal Article

Affeldt, Patrick ORCID: 0000-0002-3075-0473, Koehler, Felix Carlo ORCID: 0000-0001-9269-7420, Brensing, Karl August, Adam, Vivien, Burian, Julia, Butt, Linus, Gies, Martin, Grundmann, Franziska, Hinrichs, Steffen, Johannis, Wibke ORCID: 0000-0002-2886-7306, Kalisch, Nils, Meyer-Delpho, Matthias, Oehm, Simon ORCID: 0000-0003-4657-6091, Platen, Eva, Schoeler, Claudia, Heger, Eva, Steger, Gertrud ORCID: 0000-0002-0581-8122, Stippel, Dirk ORCID: 0000-0002-1107-0907, Ziegelhoefer, Aileen, Benzing, Thomas ORCID: 0000-0003-0512-1066, Klein, Florian ORCID: 0000-0003-1376-1792, Kurschat, Christine ORCID: 0000-0002-3646-9471, Mueller, Roman-Ulrich and Di Cristanziano, Veronica (2022). Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients. Microorganisms, 10 (1). BASEL: MDPI. ISSN 2076-2607

Affeldt, Patrick ORCID: 0000-0002-3075-0473, Koehler, Felix Carlo ORCID: 0000-0001-9269-7420, Brensing, Karl August, Gies, Martin, Platen, Eva ORCID: 0000-0003-1621-0232, Adam, Vivien, Butt, Linus, Grundmann, Franziska ORCID: 0000-0002-5766-7477, Heger, Eva, Hinrichs, Steffen, Kalisch, Nils, Oehm, Simon, Steger, Gertrud, Wirtz, Maike, Benzing, Thomas ORCID: 0000-0003-0512-1066, Stippel, Dirk ORCID: 0000-0002-1107-0907, Klein, Florian ORCID: 0000-0003-1376-1792, Kurschat, Christine ORCID: 0000-0002-3646-9471, Mueller, Roman-Ulrich and Di Cristanziano, Veronica (2022). Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients. Viruses-Basel, 14 (12). BASEL: MDPI. ISSN 1999-4915

Herrlinger, Ulrich, Schaefer, Nildas, Steinbach, Joachim Peter, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Braun, Christian, Kohnen, Ralf, Leutgeb, Barbara, Belka, Claus, Urbach, Horst, Stummer, Walter and Gies, Martin (2014). Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Wed Apr 24 22:36:02 2024 CEST.